Egfr non african american vs african american

Size: px
Start display at page:

Download "Egfr non african american vs african american"

Transcription

1 Buscar... Egfr non african american vs african american Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your. Test Summary. Creatinine-based Estimated Glomerular Filtration Rate ( egfr ) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. The neuroanatomic basis for cognitive impairment in chronic TEENney disease (CKD) is incompletely characterized. We performed advanced quantitative structural magnetic Find a comprehensive guide to possible side effects including common and rare side effects when taking Invokana (Canagliflozin Tablets) for healthcare. Previous observational studies reported J or U-shaped associations between blood pressure parameters and mortality in patients with chronic TEENney disease (CKD). Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non -small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised Christopher Lathan, MD, MS, MPH Find a cancer doctor with Dana Farber's physician directory. Read how to search for a cancer doctor by name for breast. Jun 2, Black Americans have a 2 4-fold incidence of end-stage renal disease (ESRD) compared with whites [1,2]. may be that prevalence studies are limited by the lack of accurate tools for estimation of glomerular filtration rate (GFR) in non- white populations without known CKD (egfr 60 ml/min/1.73 m2). Method. The egfr is calculated using isotope dilution mass spectrometry (IDMS )-traceable serum creatinine measurements and the patient's age (18 years and older), gender, and race (African American vs non-african American) according to the Chronic TEENney Disease Epidemiology Collaboration (CKD- EPI) equation. 4. What is egfr? egfr is short for estimated glomerular filtration rate. Your egfr is a number based on your blood test for creatinine, a waste product in your blood. It tells how well your TEENneys are working. The egfr is a good test, but it's not right for everyone. For example, this test may not be accurate if you are younger. The MDRD equation does require race (African American or non-african American), which also may not be readily available. For this reason, egfr values for both African Americans and non-african Americans are reported. The difference between the 2 estimates is typically about 20%. The patient or provider can decide. Renal function, in nephrology, is an indication of the TEENney's condition and its role in renal physiology. Glomerular filtration rate (GFR) describes the flow rate of filtered fluid through the TEENney. Creatinine clearance rate (CCr or CrCl) is the volume of blood plasma that is cleared of creatinine per unit time and is a useful. Since a patient's race is often not available to laboratories, and because mixed ethnicity can make it difficult to classify a patient's race, a general recommendation is to report the egfr values for both African Americans and non -African Americans (See Sample egfr Reports). This practice allows the provider to estimate the. It must also be adjusted if you're female or African American. The formula for determining

2 egfr is: Determining egfr Formula. Luckily for those of us who are not mathematically inclined, we can simply plug in our values to determine our egfr. For TEENren, there is another formula, because height is a greater determinant. 12) Why are there different estimated levels of GFR for African Americans, males and females, and people of different ages? 6. 13) Are there terms for races or ethnic groups other than African Americans? 7. 14) Are. 29) What problems are caused by the non-steady state of filtration markers after a change in GFR? 11. estimated GFR? 27) What problems are caused by non-steady state of filtration markers after a change in GFR? Interpretation of GFR Estimates. 28) To which.. African American). GFR is expressed in ml/min/1.73 m2, SCr is serum creatinine expressed in mg/dl, and age is expressed in years. In the MDRD Study, the. Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your TEENneys Work. Vis Medicatrix Naturae Maximizing Outcomes Using KNOWoncology.org Part 1. Jen Green, ND, FABNO Dugald Seely, ND, MSc, FABNO Heather Wright, ND, FABNO Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-smallcell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised. M. E. Martínez et al. / HEALTH 2 (2010) Copyright 2010 SciRes. Openly accessible at Approach to the Patient with Chronic TEENney Disease (CKD) Akinlolu Ojo, MD, PhD, MBA June 17, Search for articles by this author Affiliations. Division of Nephrology, TEENren s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Center for. Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. Process. The Renal Mass and Localized Renal Cancer Panel was created in 2014 by the American Urological Association Education and Research, Inc. (AUA). References. American Cancer Society. Cancer Facts & Figures Available at: Test Summary. Creatinine-based Estimated Glomerular Filtration Rate (egfr) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or Christopher Lathan, MD, MS, MPH Find a cancer doctor with Dana Farber's physician directory. Read how to search for a cancer doctor by name for breast Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your. Test Summary. Creatininebased Estimated Glomerular Filtration Rate ( egfr ) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or Find a comprehensive guide to possible side effects including common and rare side effects when taking Invokana (Canagliflozin Tablets) for healthcare Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. Previous observational studies reported J or U-shaped associations between blood pressure parameters and mortality in patients with chronic TEENney disease (CKD). The neuroanatomic basis for cognitive impairment in chronic TEENney disease (CKD) is incompletely characterized. We performed advanced quantitative structural magnetic. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non -small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised. Jun 2, Black Americans have a 2 4-fold incidence of end-stage renal disease (ESRD) compared with whites [1,2]. may be that prevalence studies are limited by the lack of accurate tools for estimation of glomerular filtration rate (GFR) in non- white populations without known CKD (egfr 60 ml/min/1.73 m2). Renal function, in nephrology, is an indication of the TEENney's condition and its role in renal physiology. Glomerular filtration rate (GFR)

3 describes the flow rate of filtered fluid through the TEENney. Creatinine clearance rate (CCr or CrCl) is the volume of blood plasma that is cleared of creatinine per unit time and is a useful. 12) Why are there different estimated levels of GFR for African Americans, males and females, and people of different ages? 6. 13) Are there terms for races or ethnic groups other than African Americans? 7. 14) Are. 29) What problems are caused by the non-steady state of filtration markers after a change in GFR? 11. It must also be adjusted if you're female or African American. The formula for determining egfr is: Determining egfr Formula. Luckily for those of us who are not mathematically inclined, we can simply plug in our values to determine our egfr. For TEENren, there is another formula, because height is a greater determinant. The MDRD equation does require race (African American or non-african American), which also may not be readily available. For this reason, egfr values for both African Americans and non-african Americans are reported. The difference between the 2 estimates is typically about 20%. The patient or provider can decide. What is egfr? egfr is short for estimated glomerular filtration rate. Your egfr is a number based on your blood test for creatinine, a waste product in your blood. It tells how well your TEENneys are working. The egfr is a good test, but it's not right for everyone. For example, this test may not be accurate if you are younger. Method. The egfr is calculated using isotope dilution mass spectrometry (IDMS )-traceable serum creatinine measurements and the patient's age (18 years and older), gender, and race (African American vs non-african American) according to the Chronic TEENney Disease Epidemiology Collaboration (CKD-EPI) equation. 4. estimated GFR? 27) What problems are caused by non-steady state of filtration markers after a change in GFR? Interpretation of GFR Estimates. 28) To which.. African American). GFR is expressed in ml/min/1.73 m2, SCr is serum creatinine expressed in mg/dl, and age is expressed in years. In the MDRD Study, the. Since a patient's race is often not available to laboratories, and because mixed ethnicity can make it difficult to classify a patient's race, a general recommendation is to report the egfr values for both African Americans and non -African Americans (See Sample egfr Reports). This practice allows the provider to estimate the. Vis Medicatrix Naturae Maximizing Outcomes Using KNOWoncology.org Part 1. Jen Green, ND, FABNO Dugald Seely, ND, MSc, FABNO Heather Wright, ND, FABNO Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. Process. The Renal Mass and Localized Renal Cancer Panel was created in 2014 by the American Urological Association Education and Research, Inc. (AUA). Search for articles by this author Affiliations. Division of Nephrology, TEENren s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Center for. M. E. Martínez et al. / HEALTH 2 (2010) Copyright 2010 SciRes. Openly accessible at Approach to the Patient with Chronic TEENney Disease (CKD) Akinlolu Ojo, MD, PhD, MBA June 17, References. American Cancer Society. Cancer Facts & Figures Available at: Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised. Test Summary. Creatinine-based Estimated Glomerular Filtration Rate (egfr) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or. Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your TEENneys Work Find a comprehensive guide to possible side effects including common and rare side effects when taking Invokana (Canagliflozin Tablets) for healthcare Epidermal growth

4 factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your. The neuroanatomic basis for cognitive impairment in chronic TEENney disease (CKD) is incompletely characterized. We performed advanced quantitative structural magnetic. Test Summary. Creatinine-based Estimated Glomerular Filtration Rate ( egfr ) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or Christopher Lathan, MD, MS, MPH Find a cancer doctor with Dana Farber's physician directory. Read how to search for a cancer doctor by name for breast. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non -small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised. Previous observational studies reported J or U-shaped associations between blood pressure parameters and mortality in patients with chronic TEENney disease (CKD). 12) Why are there different estimated levels of GFR for African Americans, males and females, and people of different ages? 6. 13) Are there terms for races or ethnic groups other than African Americans? 7. 14) Are. 29) What problems are caused by the non-steady state of filtration markers after a change in GFR? 11. Method. The egfr is calculated using isotope dilution mass spectrometry (IDMS )- traceable serum creatinine measurements and the patient's age (18 years and older), gender, and race (African American vs non-african American) according to the Chronic TEENney Disease Epidemiology Collaboration (CKD-EPI) equation. 4. It must also be adjusted if you're female or African American. The formula for determining egfr is: Determining egfr Formula. Luckily for those of us who are not mathematically inclined, we can simply plug in our values to determine our egfr. For TEENren, there is another formula, because height is a greater determinant. What is egfr? egfr is short for estimated glomerular filtration rate. Your egfr is a number based on your blood test for creatinine, a waste product in your blood. It tells how well your TEENneys are working. The egfr is a good test, but it's not right for everyone. For example, this test may not be accurate if you are younger. Since a patient's race is often not available to laboratories, and because mixed ethnicity can make it difficult to classify a patient's race, a general recommendation is to report the egfr values for both African Americans and non -African Americans (See Sample egfr Reports). This practice allows the provider to estimate the. estimated GFR? 27) What problems are caused by non-steady state of filtration markers after a change in GFR? Interpretation of GFR Estimates. 28) To which.. African American). GFR is expressed in ml/min/1.73 m2, SCr is serum creatinine expressed in mg/dl, and age is expressed in years. In the MDRD Study, the. Renal function, in nephrology, is an indication of the TEENney's condition and its role in renal physiology. Glomerular filtration rate (GFR) describes the flow rate of filtered fluid through the TEENney. Creatinine clearance rate (CCr or CrCl) is the volume of blood plasma that is cleared of creatinine per unit time and is a useful. Jun 2, Black Americans have a 2 4-fold incidence of endstage renal disease (ESRD) compared with whites [1,2]. may be that prevalence studies are limited by the lack of accurate tools for estimation of glomerular filtration rate (GFR) in nonwhite populations without known CKD (egfr 60 ml/min/1.73 m2). The MDRD equation does require race (African American or non-african American), which also may not be readily available. For this reason, egfr values for both African Americans and non- African Americans are reported. The difference between the 2 estimates is typically about 20%. The patient or provider can decide. Search for articles by this author Affiliations. Division of Nephrology, TEENren s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Center for. Process. The Renal Mass and Localized Renal Cancer Panel was

5 created in 2014 by the American Urological Association Education and Research, Inc. (AUA). Approach to the Patient with Chronic TEENney Disease (CKD) Akinlolu Ojo, MD, PhD, MBA June 17, Test Summary. Creatinine-based Estimated Glomerular Filtration Rate (egfr) Clinical Use: Detect chronic TEENney disease (CKD) in adults. Monitor CKD therapy and/or. References. American Cancer Society. Cancer Facts & Figures Available at: Vis Medicatrix Naturae Maximizing Outcomes Using KNOWoncology.org Part 1. Jen Green, ND, FABNO Dugald Seely, ND, MSc, FABNO Heather Wright, ND, FABNO Chronic TEENney disease (CKD) is a condition characterized by a gradual loss of TEENney function over time. To read more about TEENney function, see How Your TEENneys Work. Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutationpositive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised. M. E. Martínez et al. / HEALTH 2 (2010) Copyright 2010 SciRes. Openly accessible at

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta A New Approach for Evaluating Renal Function and Predicting Risk William McClellan, MD, MPH Emory University Atlanta Goals Understand the limitations and uses of creatinine based measures of kidney function

More information

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC Creatinine & egfr A Clinical Perspective Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC CLINICAL CONDITIONS WHERE ASSESSMENT OF GFR IS IMPORTANT Stevens et al. J Am Soc Nephrol 20: 2305

More information

Assessing Renal Function: What you Didn t Know You Didn t Know

Assessing Renal Function: What you Didn t Know You Didn t Know Assessing Renal Function: What you Didn t Know You Didn t Know Presented By Tom Wadsworth PharmD, BCPS Associate Clinical Professor UAA/ISU Doctor of Pharmacy Program Idaho State University College of

More information

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253

More information

Update on HIV-Related Kidney Diseases. Agenda

Update on HIV-Related Kidney Diseases. Agenda Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED

More information

Renal function vs chemotherapy dosing

Renal function vs chemotherapy dosing Renal function vs chemotherapy dosing Jenny Casanova Senior Clinical Pharmacist Repatriation General Hospital Daw Park 1 Methods of estimating renal function Cockcroft-Gault (1976) C-G using ideal vs actual

More information

מסקנות מיישום סטנדרטיזציה של בדיקת קראטינין : שימוש בנוסחאות לחישוב egfr

מסקנות מיישום סטנדרטיזציה של בדיקת קראטינין : שימוש בנוסחאות לחישוב egfr מסקנות מיישום סטנדרטיזציה של בדיקת קראטינין : שימוש בנוסחאות לחישוב egfr תכנית המפגש: דרישות לסטנדרטיזציה של בדיקת קראטינין ד"ר מריאל קפלן, מנהלת אגף המעבדות, רמב"ם - הקריה הרפואית לבריאות האדם שימוש מושכל

More information

Acute renal failure Definition and detection

Acute renal failure Definition and detection Acute renal failure Definition and detection Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM Definition Acute Renal Failure Acute Kidney Injury

More information

How and why to measure renal function in patients with liver disease?

How and why to measure renal function in patients with liver disease? ow and why to measure renal function in patients with liver disease? P. Angeli, Dept. of Medicine, Unit of Internal Medicine and epatology (), University of Padova (Italy) pangeli@unipd.it 10th Paris epatology

More information

Carboplatin Time to Drop the Curtain on the Dosing Debate

Carboplatin Time to Drop the Curtain on the Dosing Debate Carboplatin Time to Drop the Curtain on the Dosing Debate Jon Herrington, Pharm.D., BCPS, BCOP Judith Smith, Pharm.D., BCOP, CPHQ, FCCP, FISOPP Scott Soefje, Pharm.D., MBA, BCOP Heimberg J, et al. N Engl

More information

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives Evaluation of egfr and mgfr in CKD Use of CKD staging with case scenario Assessment of kidney function in CKD in adults Learning Objectives 台大雲林分院楊淑珍藥師 2017/03/11 Chronic Kidney Disease (CKD) Based on

More information

Have you seen a patient like Elaine *?

Have you seen a patient like Elaine *? (linagliptin) 5mg tablets Have you seen a patient like Elaine *? *Hypothetical patient profile Elaine * : 60 years old Housewife *Hypothetical patient profile ELAINE*: T2D Patient with early signs of kidney

More information

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening

More information

Have you seen a patient like Carol *?

Have you seen a patient like Carol *? (linagliptin) 5mg tablets Have you seen a patient like Carol *? *Hypothetical patient profile Carol * : 70 years old Retired schoolteacher *Hypothetical patient profile CAROL*: T2D patient with moderate

More information

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What

More information

Epidemiology of CKD in Children

Epidemiology of CKD in Children Epidemiology of CKD in Children Ali Düzova, M.D. Hacettepe University Faculty of Medicine Pediatric Nephrology and Rheumatology Unit Ankara CKD Course 03 June 2011, İstanbul Aim & Plan Causes of CKD in

More information

KEEP 2.0 Annual Data Report Chapter Five

KEEP 2.0 Annual Data Report Chapter Five KEEP 2. Annual Data Report Chapter Five Figure 5.1 percent distribution of KEEP participants with elevated serum creatinine levels, overall & by age 16 Percent of participants 12 8 4 All

More information

Primary Care Approach to Management of CKD

Primary Care Approach to Management of CKD Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low

More information

Case Studies: Renal and Urologic Impairments Workshop

Case Studies: Renal and Urologic Impairments Workshop Case Studies: Renal and Urologic Impairments Workshop Justine Lee, MD, DBIM New York Life Insurance Co. Gina Guzman, MD, DBIM, FALU, ALMI Munich Re AAIM Triennial October, 2012 The Company You Keep 1 Case

More information

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Ιατρική Σχολή ΑΠΘ Νοσοκομείο ΑΧΕΠA Θεσσαλομίκη Kidney in body homeostasis Excretory function Uremic toxins removal Vascular volume maintainance Fluid-electrolyte

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Special Challenges and Co-Morbidities

Special Challenges and Co-Morbidities Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine

More information

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage

More information

KEEP S u m m a r y F i g u r e s. American Journal of Kidney Diseases, Vol 53, No 4, Suppl 4, 2009:pp S32 S44.

KEEP S u m m a r y F i g u r e s. American Journal of Kidney Diseases, Vol 53, No 4, Suppl 4, 2009:pp S32 S44. 28 S u m m a r y F i g u r e s American Journal of Kidney Diseases, Vol 53, No 4, Suppl 4, 29:pp S32 S44. S32 Definitions S33 Data Analyses Diabetes Self-reported diabetes, self reported diabetic retinopathy,

More information

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests Renal Tests Holly Kramer MD MPH Associate Professor of Public Health Sciences and Medicine Division of Nephrology and Hypertension Loyola University of Chicago Stritch School of Medicine Renal Tests 1.

More information

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH SCIENTIFIC DIRECTOR KIDNEY HEALTH RESEARCH COLLABORATIVE - UCSF CHIEF - GENERAL INTERNAL MEDICINE, SAN FRANCISCO

More information

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure. Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Introduction to Clinical Diagnosis Nephrology

Introduction to Clinical Diagnosis Nephrology Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College

More information

Two: Chronic kidney disease identified in the claims data. Chapter

Two: Chronic kidney disease identified in the claims data. Chapter Two: Chronic kidney disease identified in the claims data Though leaves are many, the root is one; Through all the lying days of my youth swayed my leaves and flowers in the sun; Now may wither into the

More information

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56 21 Summary Figures S32 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving medication for diabetes, or elevated blood glucose (WHO); fasting blood sugar

More information

KEEP 2009 Summary Figures

KEEP 2009 Summary Figures S4 29 Summary Figures American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 21:pp S4-S57 S41 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving

More information

Standardization of. S.M.Boutorabi DCLS,PhD

Standardization of. S.M.Boutorabi DCLS,PhD Standardization of Creatinine Assay S.M.Boutorabi DCLS,PhD Chronic kidney disease (CKD) is a major public health problem in developed countries Why measure serum creatinine? Jaffe Reaction Creatinine +picric

More information

Chronic Kidney Disease: Optimal and Coordinated Management

Chronic Kidney Disease: Optimal and Coordinated Management Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,

More information

Creatinine (serum, plasma)

Creatinine (serum, plasma) Creatinine (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Creatinine 1.2 Alternative names None 1.3 Description of analyte Creatinine is a heterocyclic nitrogenous compound (IUPAC

More information

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set

More information

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program

More information

AKI: definitions, detection & pitfalls. Jon Murray

AKI: definitions, detection & pitfalls. Jon Murray AKI: definitions, detection & pitfalls Jon Murray Previous conventional definition Acute renal failure (ARF) An abrupt and sustained decline in renal excretory function due to a reduction in glomerular

More information

Correspondence should be addressed to Maisarah Jalalonmuhali;

Correspondence should be addressed to Maisarah Jalalonmuhali; Hindawi International Journal of Nephrology Volume 2017, Article ID 2901581, 7 pages https://doi.org/10.1155/2017/2901581 Research Article Comparative Performance of Creatinine-Based Estimated Glomerular

More information

Nephrologists. from. All physicians Patients Health care system Policy makers World health leaders Researchers. Clinical laboratories

Nephrologists. from. All physicians Patients Health care system Policy makers World health leaders Researchers. Clinical laboratories Creatinine standardization The most important expectation of Nephrologists All physicians Patients Health care system Policy makers World health leaders Researchers Drug manufacturer Clinical laboratories

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children *H W Dilanthi 1, G A M Kularatnam 1, S Jayasena 1, E Jasinge 1, D B D L Samaranayake

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets

More information

Egfr non-afr. american blood work

Egfr non-afr. american blood work Egfr non-afr. american blood work 08/21/2017 Code for assay of thyroid stim hormone dx code 08/23/2017 Icd 10 code for peripheral neuropathy in feet 08/24/2017 -Jennifer aniston nipslip -Urine drug screen

More information

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National

More information

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64 211 Summary Figures S4 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving medication for diabetes, or elevated

More information

Egfr non african american blood work

Egfr non african american blood work Egfr non african american blood work 10/20/2017 David jeremiah cruise to alaska 10/22/2017 Mystery stories with comprehension questions 10/24/2017 -Adderall mouth swab drug test -Cvs myhr employee health

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Augmented Renal Clearance: Let s Get the Discussion Flowing

Augmented Renal Clearance: Let s Get the Discussion Flowing Augmented Renal Clearance: Let s Get the Discussion Flowing Terry Makhoul, PharmD PGY-2 Emergency Medicine Pharmacy Resident University of Rochester Medical Center Strong Memorial Hospital Disclosures

More information

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Larry Lehrner, Ph.D.,M.D. llehrner@ksosn.com Commercial Support Acknowledgement: There is no outside support for this activity Financial Disclosure: stocks > 50,000 Bayer, J&J, Norvartis,Novo

More information

Understanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016

Understanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016 Understanding Your Kidneys Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016 Today s Discussion - The Role of your kidneys Common causes of kidney disease Treatment for kidney

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

GFR and Drug Dosage Adaptation: Are We still in the Mist?

GFR and Drug Dosage Adaptation: Are We still in the Mist? GFR and Drug Dosage Adaptation: Are We still in the Mist? Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM I have no conflict of interest to declare

More information

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

From Department of Medicine, David Geffen School of Medicine at UCLA.

From Department of Medicine, David Geffen School of Medicine at UCLA. FROM ISHIB 2009 THE PROS AND CONS OF STAGING CHRONIC KIDNEY DISEASE Background and Objectives: In 2002 the National Kidney Foundation Kidney Disease Outcomes Quality Initiative presented a new definition

More information

8/12/2016. Diabetes Management Across the Spectrum of Kidney Function. Andrew Bzowyckyj. Learning Objectives. Ashley Crowl

8/12/2016. Diabetes Management Across the Spectrum of Kidney Function. Andrew Bzowyckyj. Learning Objectives. Ashley Crowl Diabetes Management Across the Spectrum of Kidney Function Andrew Bzowyckyj PharmD, BCPS, CDE Clinical Assistant Professor School of Pharmacy University of Missouri-Kansas City Kansas City, MO Ashley Crowl

More information

Nephrology referral - Does my patient need it? Disclosure

Nephrology referral - Does my patient need it? Disclosure Nephrology referral - Does my patient need it? Sophia Chou, MD MSc March 10, 2018 Faculty: Sophia Chou Disclosure Relationships with commercial interest: None Potential conflict of interest: None 1 Objectives

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

BASELINE CHARACTERISTICS OF THE STUDY POPULATION Study Summary DAILY ORAL SODIUM BICARBONATE PRESERVES GLOMERULAR FILTRATION RATE BY SLOWING ITS DECLINE IN EARLY HYPERTENSIVE NEPHROPATHY This was a 5-year, single-center, prospective, randomized, placebo-controlled,

More information

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Estimates of glomerular filtration rate (GFR) from serum

Estimates of glomerular filtration rate (GFR) from serum Annals of Internal Medicine Review Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization A Systematic Review Amy Earley, BS; Dana Miskulin, MD, MS; Edmund J. Lamb,

More information

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA Management of New-Onset Proteinuria in the Ambulatory Care Setting Akinlolu Ojo, MD, PhD, MBA Urine dipstick results Negative Trace between 15 and 30 mg/dl 1+ between 30 and 100 mg/dl 2+ between 100 and

More information

TOPICS. Continuing Education April 2015 Volume 17 Number 2. Journal of. Inside This Issue. Official publication of the American Medical Technologists

TOPICS. Continuing Education April 2015 Volume 17 Number 2. Journal of. Inside This Issue. Official publication of the American Medical Technologists Journal of TOPICS & ISSUES Official publication of the American Medical Technologists Continuing April 2015 Volume 17 Number 2 Inside This Issue Identifying Chronic Kidney Disease: An Overview of the Equations

More information

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;inpress Published online in press HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE

More information

Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease

Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Kidney Diseases Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease Osama El Minshawy, 1 Eman El-Bassuoni 2 Original Paper 1 Department

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

Chapter 2: Identification and Care of Patients with CKD

Chapter 2: Identification and Care of Patients with CKD Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral CKD IN THE CLINIC Family Physician Refresher Course Lisa M. Antes, MD April 19, 2017 No disclosures Session Content 1. 2. Recommendations for commonly used medications in CKD Basic principles /patient

More information

Lecture-2 Review of the previous lecture:

Lecture-2 Review of the previous lecture: Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,

More information

Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD

Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD Metformin: Only oral diabetes medication with proven benefits on cardiovascular morbidity and mortality Inexpensive medication

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

Cystatin C: A New Approach to Improve Medication Dosing

Cystatin C: A New Approach to Improve Medication Dosing Cystatin C: A New Approach to Improve Medication Dosing Erin Frazee Barreto, PharmD, MSc, FCCM Assistant Professor of Pharmacy and Medicine Kern Scholar, Center for the Science of Health Care Delivery

More information

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis

More information

TDM of Digoxin. Use of Digoxin Serum Concentrations to Alter Dosages

TDM of Digoxin. Use of Digoxin Serum Concentrations to Alter Dosages TDM Lecture 8 5 th Stage TDM of Digoxin Use of Digoxin Serum Concentrations to Alter Dosages Linear Pharmacokinetics Method This method is used in steady-state condition. We compute the new dose of digoxin

More information

AKI-6 Epidemiology of Acute Kidney Injury

AKI-6 Epidemiology of Acute Kidney Injury FACULTY OF MEDICINE AND HEALTH SCIENCES Academic Year 2011-2012 AKI-6 Epidemiology of Acute Kidney Injury Anne NOBELS Promotor: Prof. Dr. E. Hoste Co-promotor: Prof. Dr. J. Kellum (Pittsburg) Dissertation

More information

Department of Clinical Pathology, Faculty of Medicine Padjadjaran University-Dr. Hasan Sadikin General Hospital 2

Department of Clinical Pathology, Faculty of Medicine Padjadjaran University-Dr. Hasan Sadikin General Hospital 2 Original Article Comparison of Estimated Glomerular Filtration Rate Mean Value of HARUS 15-30-60, HADI, and ASIAN Fomula Accuracy in Diabetes Mellitus Type 2 Sylvia Rachmayati, 1 Ida Parwati, 1 Abdul Hadi

More information

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy)

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Patient information Oxford Kidney Unit If you have been told you have chronic kidney disease (CKD) due to diabetic nephropathy this leaflet

More information

RENAL FUNCTION ASSESSMENT ASSESSMENT OF GLOMERULAR FUNCTION ASSESSMENT OF TUBULAR FUNCTION

RENAL FUNCTION ASSESSMENT ASSESSMENT OF GLOMERULAR FUNCTION ASSESSMENT OF TUBULAR FUNCTION Measured GFR (mgfr mgfr) and Estimated t GFR (egfr egfr) R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RENAL FUNCTION ASSESSMENT ASSESSMENT OF GLOMERULAR FUNCTION ASSESSMENT OF TUBULAR

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Dr Poorva Jain MBChB MRCP. Page 1 of 375

Dr Poorva Jain MBChB MRCP. Page 1 of 375 Can Routinely Collected Primary Care Data Determine the Prevalence of Chronic Kidney Disease And Predict Clinical Events In Patients With Stages 3 of the Disease? Dr Poorva Jain MBChB MRCP Page 1 of 375

More information

Individual Study Table Referring to Part of Dossier: Volume: Page:

Individual Study Table Referring to Part of Dossier: Volume: Page: Synopsis Abbott Laboratories Name of Study Drug: Paricalcitol Capsules (ABT-358) (Zemplar ) Name of Active Ingredient: Paricalcitol Individual Study Table Referring to Part of Dossier: Volume: Page: (For

More information

Early Identification of the Diabetic Nephropathy; Beyond Creatinine

Early Identification of the Diabetic Nephropathy; Beyond Creatinine C H A P T E R 30 Early Identification of the Diabetic Nephropathy; Beyond Creatinine Vivek Pal Singh, S Avinash INTRODUCTION Diabetic nephropathy (DN) is the single most frequent cause of end-stage renal

More information

INDEX WORDS: Awareness; chronic kidney disease; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); estimated glomerular filtration rate.

INDEX WORDS: Awareness; chronic kidney disease; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); estimated glomerular filtration rate. KEEP 2010 Comparison of CKD Awareness in a Screening Population Using the Modification of Diet in Renal Disease (MDRD) Study and CKD Epidemiology Collaboration (CKD-EPI) Equations Manjula Kurella Tamura,

More information

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population 3176 Nephrol Dial Transplant (2011) 26: 3176 3181 doi: 10.1093/ndt/gfr003 Advance Access publication 16 February 2011 Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian

More information

Office Management of Reduced GFR Practical advice for the management of CKD

Office Management of Reduced GFR Practical advice for the management of CKD Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE

More information

Tenofovir plasma exposures and Creatinine Clearance changes in 1st line Regimen of African patients in Cameroon and Senegal: ANRS12115 DAYANA study

Tenofovir plasma exposures and Creatinine Clearance changes in 1st line Regimen of African patients in Cameroon and Senegal: ANRS12115 DAYANA study Abstract O_03 Tenofovir plasma exposures and Creatinine Clearance changes in 1st line Regimen of African patients in Cameroon and Senegal: ANRS12115 DAYANA study M.P. Lê Pharmacy Resident Clinical Pharmacology

More information

Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009

Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009 Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009 Minesh Khatri Internal Medicine R2 Background Patients

More information